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High expression of telomerase in embryonic stem cells (ESCs) is important for their maintenance, but whether
telomere length affects lineage commitment is unknown. In this issue of Cell Stem Cell, Pucci et al. (2013)
reveal that ESCs with short telomeres exhibit unstable differentiation by inducing altered DNA methylation.Long term self-renewal of stem cells re-
quires faithful replication of telomeres by
the enzyme telomerase. Unlike most
proliferating cells, embryonic stem cells
(ESCs) express an abundance of telome-
rase (Kim et al., 1994). The primary con-
sequence of a lack or deficiency of
telomerase in proliferating cells is the
gradual attrition of telomeres and, ulti-
mately, cell senescence once a sufficient
number of telomeres become critically
short (Bodnar et al., 1998). Thus, high
levels of telomerase in ESCs likely ensure
that their in vivo counterparts in the early
embryo have long telomeres and suffi-
cient replicative potential to prevent
deleterious effects during prenatal and
postnatal development. Now, in this issue
ofCell StemCell, Fabio et al. report for the
first time that there are additional prese-
nescent consequences of aberrantly
short telomeres in ESCs that adversely
affect the ability of these cells to retain a
differentiated state (Pucci et al., 2013).
The study byHarrington and colleagues
(Pucci et al., 2013) used ESCs derived
from mice (Liu et al., 2000) that lack the
gene encoding the catalytic component
of telomerase, telomerase reverse tran-
scriptase (Tert), to query the role of telo-
meres in ESC biology. They discovered
that late-passage Tert/ ESCs with short
telomeres, including a fraction of chromo-
somal ends that entirely lack detectable
telomeric DNA (dysfunctional telomeres),
express unusually high levels of the plu-
ripotency-promoting factor Nanog (Pucci
et al., 2013). Furthermore, this effect on
pluripotency factor expression was spe-
cific for Nanog but not for other factors
such as Oct4 or Sox2. A more detailed
analysis into the mechanism leading to
high levels of Nanog expression in these
cells revealed a reduction in trimethylated
histone H3 lysine 27(H3K27me3) in the
Nanog promoter, whose reduction waspreviously shown to be associated with
elevated Nanog expression (Shen et al.,
2008). Reparation of telomeres in these
cells by reintroduction of Tert both
reduced Nanog expression and restored
H3K27me3 to wild-type levels in the
Nanog promoter, demonstrating a direct
consequence of reduced telomere length
on Nanog expression in ESCs.
To begin to assess the functional con-
sequences of elevated Nanog levels in
Tert/ ESC, Pucci et al. induced these
cells to differentiate by treating them
with retinoic acid (RA). While Nanog
expression was initially diminished after
RA-induced differentiation, akin to what
is observed in wild-type ESCs, subse-
quent addition of leukemia inhibitory
factor (LIF) after a few days of growth
led to upregulated Nanog expression in
the Tert/ ESC-harboring short telo-
meres, but not in wild-type ESC. More-
over, this was accompanied by a marked
increase in ESC colony formation in these
cells, whichwas not observed in wild-type
ESC. Restoration of telomeres by reintro-
duction of Tert into the Tert/ ESC
prevented the ability of LIF to reactivate
Nanog expression following the RA-
induced differentiation of these cells,
again demonstrating that this observation
is a consequence of shortened telomeres.
Furthermore, the RA-induced differenti-
ated state could be stabilized by RNA
interference-mediated knockdown of
Nanog in these cells, showing that this ef-
fect is primarily, if not entirely, attributed
to elevated Nanog expression.
Further analysis by Pucci et al. into the
epigenetic effects of aberrantly shortened
telomeres in Tert/ ESC revealed
changes in DNA methylation (methyl-
CpG), with global hypomethylation occur-
ring throughout the genome and not
solely at the Nanog promoter. This finding
prompted Pucci et al. to assess the levelsCell Stem Ceof de novo methyl transferases (Dnmt) in
the Tert/ ESCs. Interestingly, Dnmt3a
and Dnmt3b, but not Dnmt1, were
reduced compared to wild-type ESC.
Furthermore, enforced expression of
Dnmt3b was sufficient not only to restore
the genome-wide methylation to a level
comparable to what is observed in the
wild-type ESC genome but also to stabi-
lize the differentiated state of these cells
following RA treatment.
Thus, telomerase deficiency and, more
specifically, the resulting telomere attri-
tion in ESCs can lead not only to eventual
cell senescence and/or cell death (Niida
et al., 1998) but also to genome-wide
hypomethylation and unstable differentia-
tion of cells. However, the exact mecha-
nism bywhich critical telomere shortening
leads to genome-wide hypomethylation
and subsequent aberrant gene expres-
sion, such as elevated Nanog, remains
to be determined. The reintroduction of
Tert into the late-passage telomerase-
deficient ESC rescues both the telomere
dysfunction phenotype and the hypome-
thylation-attributed unstable differentia-
tion phenotype of these cells, implying
that the presence of dysfunctional, telo-
mere-free ends is somehow signaling
a response that involves, perhaps in
addition to other things, genome-wide
hypomethylation (Figure 1A). However,
rescuing the Tert/ ESC by enforced
Tert expression also leads to extensive
telomere lengthening (Pucci et al., 2013).
Therefore, a possible alternative explana-
tion could be an effect of compromised
telomere length, possibly via altered
telomeric chromatin or reduced levels of
histones (O’Sullivan et al., 2010), on
Dnmt3b expression (Figure 1B). Prese-
nescent epigenetic affects of telomere
attrition have recently been documented
for late-passage human fibroblasts,
which do not contain dysfunctionalll 12, April 4, 2013 ª2013 Elsevier Inc. 383
Figure 1. Hypothetical Mechanisms for Upregulation of Nanog in Late-Passage Tert–/– ESC
(A) One possibility is that the accumulation of telomere-free chromosomal ends elicits a DNA damage
response, which, in the early stages, causes a reduction in genome-wide methylation. (B) Alternatively,
telomeres that are compromised, but still retain some protective capping function, could affect DNA
methylation by evoking a decline in histone synthesis or perturbing expression of distal genes due to al-
terations in telomeric chromatin.
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Previewstelomeres (i.e., telomere-free chromo-
somal ends) (O’Sullivan et al., 2010). Addi-
tional studies will be required to clearly
distinguish between these possibilities.
The effect of shortened telomeres on
the differentiated state of ESC reported
by Pucci et al. implies that there could
be similar effects in other types of stem
cells at advanced replicative age. This
may be particularly interesting to assess384 Cell Stem Cell 12, April 4, 2013 ª2013 Elin adult stem cells for highly proliferative
tissues, such as hematopoietic stem
cells, which undergo extensive telomere
shortening during human aging (Vaziri
et al., 1994). Furthermore, many different
types of tumors have now been shown
to rely on cancer stem cells for growth,
and many types of human tumors have
short, dysfunctional telomeres (Shay and
Wright, 2011). Thus, it will also be of inter-sevier Inc.est to assess the stability of the differenti-
ated state for cancer stem cells, as well as
the expression of self-renewing factors
such as Nanog, particularly in tumors
with short telomeres.REFERENCES
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